Amorphous (a-polymorphic) psilocybin
Grant
US12590110B2
Kind: B2
Mar 31, 2026
Assignee
Diamond Therapeutics Inc.
Inventors
Judith Blumstock, David Roger Brown, Christian Steup, Marc Zeplichal
Abstract
Disclosed herein are compositions comprising amorphous psilocybin. The amorphous psilocybin may be a synthetic, a-polymorphic psilocybin. Also disclosed herein are methods of treatment using amorphous psilocybin and methods of manufacturing amorphous psilocybin.
CPC Classifications
C07F 9/5728
A61K 9/145
A61K 9/19
A61K 31/675
Filing Date
2024-07-05
Application No.
18764635
Claims
18